Zdrowie i gospodarka · 29/11/2004

FDA Clears 7.5% and 8.4% Sodium Bicarbonate Injection for Sale

The Food and Drug Administration (FDA) has determined that 7.5% and 8.4% sodium bicarbonate injection in polyethylene terephthalate (PET) Abboject vials were not withdrawn from sale due to safety or effectiveness concerns, paving the way for FDA approval of abbreviated new drug applications (ANDAs) for these products.